Clinical Trial Update: Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism [NA]

View source ↗

Summary

A completed clinical trial assessed the impact of beta-glucan consumption on the intestinal microbiota and glucose and lipid metabolism in individuals with meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperglycemia
• Hypertension
• Metabolic Syndrome
• Obesity Abdominal

Drugs mentioned

• Beta-glucans (beta-glucan)

Snippet

Sponsor: Mlinotest Zivilska Industrija d.d. | Conditions: Metabolic Syndrome, Dyslipidemia | NA | Status: COMPLETED | Results posted: 2019-06-03